Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aeollanthus pubescens leaf essential oil is a natural botanical extract obtained from the leaves of *Aeollanthus pubescens*, an annual herbaceous plant native to West Africa. The essential oil is rich in monoterpenes, with carvacrol, thymol, thymyl acetate, and ɣ-terpinene identified as its major chemical constituents. It is primarily being investigated for its eco-friendly insecticidal properties, demonstrating significant larvicidal and adulticidal activity against *Anopheles gambiae*, the major malaria vector. Additionally, the oil has shown potential antibacterial activity against multidrug-resistant strains of *Escherichia coli* and *Salmonella*, as well as antioxidant and anti-inflammatory properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aeollanthus pubescens leaf essential oil.